FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pertti Mustajoki

Research Profile

Disorders

Geographic Areas

Finland

Procedures

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Alleles

Co-author Network

Publications

TOP 3
Samuli I Saarni; Pertti Mustajoki; Suoma E Saarni; Heidi Anttila; Tuija S Ikonen; Vesa Koivukangas; Antti Malmivaara
Ethical issues of obesity surgery--a health technology assessment.
Samuli I Saarni; Heidi Anttila; Suoma E Saarni; Pertti Mustajoki; Vesa Koivukangas; Tuija S Ikonen; Antti Malmivaara
[Ethical aspects of bariatric surgery].
Tuija Kumpulainen; Heidi Anttila; Pertti Mustajoki; Mikael Victorzon; Samuli I Saarni; Antti Malmivaara; Tuija S Ikonen
[Provision of surgical treatment for the morbidly obese in Finland].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pertti Mustajoki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Samuli I Saarni; Pertti Mustajoki; Suoma E Saarni; Heidi Anttila; Tuija S Ikonen; Vesa Koivukangas; Antti Malmivaara
Ethical issues of obesity surgery--a health technology assessment.
Obesity surgery 2011;21(9):1469-76.
2009: Samuli I Saarni; Heidi Anttila; Suoma E Saarni; Pertti Mustajoki; Vesa Koivukangas; Tuija S Ikonen; Antti Malmivaara
[Ethical aspects of bariatric surgery].
Duodecim; lääketieteellinen aikakauskirja 2009;125(20):2280-6.
2009: Tuija Kumpulainen; Heidi Anttila; Pertti Mustajoki; Mikael Victorzon; Samuli I Saarni; Antti Malmivaara; Tuija S Ikonen
[Provision of surgical treatment for the morbidly obese in Finland].
Duodecim; lääketieteellinen aikakauskirja 2009;125(20):2275-9.
2009: Mikael Victorzon; Pertti Mustajoki; Helena Gylling; Heidi Anttila; Tuija S Ikonen; Antti Malmivaara; Vesa Koivukangas
[Effectiveness and safety of bariatric surgery].
Duodecim; lääketieteellinen aikakauskirja 2009;125(20):2257-64.
2009: Pertti Mustajoki; Vesa Koivukangas; Helena Gylling; Antti Malmivaara; Tuija S Ikonen; Mikael Victorzon
[Where does obesity stand in health care--every alternative into use].
Duodecim; lääketieteellinen aikakauskirja 2009;125(20):2249-55.
2007: Pekka Mustonen; Pertti Mustajoki
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2007;123(1):11-2.
2007: Bjørn Richelsen; Serena Tonstad; Stephan Rössner; Søren Toubro; Leo Niskanen; Sten Madsbad; Pertti Mustajoki; Aila Rissanen
Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
Diabetes care 2007;30(1):27-32.
2006: Pertti Mustajoki
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2006;122(10):1256-60.
2006: Pertti Mustajoki; Jarmo Kaukua
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2006;122(10):1207-8.
2005: Pertti Mustajoki
[Doctor's lanterns and candles-in the footsteps of Konrad Reijo Waara].
Duodecim; lääketieteellinen aikakauskirja 2005;121(23):2589-91.
2004: Leo Niskanen; David E Laaksonen; Kari Punnonen; Pertti Mustajoki; Jarmo Kaukua; Aila Rissanen
Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
Diabetes, obesity & metabolism 2004;6(3):208-15.
2004: Soili Kajaste; Pirkko E Brander; Tiina Telakivi; Markku Partinen; Pertti Mustajoki
A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study.
Sleep medicine 2004;5(2):125-31.
2004: Pertti Mustajoki
[Liposuction does not heal diabetes and improve arterial risk factors].
Duodecim; lääketieteellinen aikakauskirja 2004;120(20):2480; author reply 2481.
2004: Pertti Mustajoki; Minna Kaila
[How to explain risks of diseases to a patient].
Duodecim; lääketieteellinen aikakauskirja 2004;120(20):2465-9.
2004: Pertti Mustajoki
[Dietary counseling as the doctor's tool].
Duodecim; lääketieteellinen aikakauskirja 2004;120(2):116-8.
2003: Elina Suviolahti; Laura J Oksanen; Miina Ohman; Rita M Cantor; Martin Ridderstrale; Tiinamaija Tuomi; Jaakko Kaprio; Aila Rissanen; Pertti Mustajoki; Pekka Jousilahti; Erkki Vartiainen; Kaisa Silander; Riika Kilpikari; Veikko Salomaa; Leif Groop; Kimmo Kontula; Leena Peltonen; Päivi Pajukanta
The SLC6A14 gene shows evidence of association with obesity.
The Journal of clinical investigation 2003;112(11):1762-72.
2003: Jarmo Kaukua; Tuula Pekkarinen; Timo Sane; Pertti Mustajoki
Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification--a 2-y follow-up study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(10):1233-41.
2003: Jarmo Kaukua; Tuula Pekkarinen; Timo Sane; Pertti Mustajoki
Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification: a 2-y follow-up study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(9):1072-80.
2003: Jarmo Kaukua; Tuula Pekkarinen; Timo Sane; Pertti Mustajoki
Sex hormones and sexual function in obese men losing weight.
Obesity research 2003;11(6):689-94.
2003: Pertti Mustajoki
[Physician and medicalisation].
Duodecim; lääketieteellinen aikakauskirja 2003;119(19):1869-73.
2003: Pertti Mustajoki; Pekka Louhiala
[Good and bad medicalisation].
Duodecim; lääketieteellinen aikakauskirja 2003;119(19):1855-6.
2003: Tari Haahtela; Otto Lindberg; Pertti Mustajoki
[The transition period of the medical profession--from where the support?].
Duodecim; lääketieteellinen aikakauskirja 2003;119(10):974-5.
2003: Risto Roine; Minna Kaila; Matti Nuutinen; Taina Mäntyranta; Lauri Nuutinen; Ossi Auvinen; Pertti Mustajoki
[The execution of current treatment praxis recommendations in the specialized health care ].
Duodecim; lääketieteellinen aikakauskirja 2003;119(5):399-406.
2003: Camilla Schalin-Jäntti; Kaisa Valli-Jaakola; Laura J Oksanen; Eeva Martelin; K Laitinen; Tom Krusius; Pertti Mustajoki; Markku Heikinheimo; Kimmo Kontula
Melanocortin-3-receptor gene variants in morbid obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(1):70-4.
2002: Mikael von und zu Fraunberg; Kaisa Timonen; Pertti Mustajoki; Raili Kauppinen
Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients.
European journal of human genetics : EJHG 2002;10(10):649-57.
2002: Jarmo Kaukua; Tuula Pekkarinen; Timo Sane; Pertti Mustajoki
Health-related quality of life in WHO class II-III obese men losing weight with very-low-energy diet and behaviour modification: a randomised clinical trial.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(4):487-95.
2002: Pertti Mustajoki; Sami Mustajoki
[When you cross your hands, which of the thumbs is on the top?].
Duodecim; lääketieteellinen aikakauskirja 2002;118(23):2367-71.
2001: Raili Kauppinen; Kaisa Timonen; Mikael von und zu Fraunberg; E Laitinen; Heikki Ahola; R Tenhunen; S Taketani; Pertti Mustajoki
Homozygous variegate porphyria: 20 y follow-up and characterization of molecular defect.
The Journal of investigative dermatology 2001;116(4):610-3.
2001: Pertti Mustajoki; Tuula Pekkarinen
Very low energy diets in the treatment of obesity.
Obesity reviews : an official journal of the International Association for the Study of Obesity 2001;2(1):61-72.
2000: Miina Ohman; Laura J Oksanen; Jaakko Kaprio; Markku Koskenvuo; Pertti Mustajoki; Aila Rissanen; J Salmi; Kimmo Kontula; Leena Peltonen
Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24.
The Journal of clinical endocrinology and metabolism 2000;85(9):3183-90.
2000: Sami Mustajoki; M Laine; M Lahtela; Pertti Mustajoki; Leena Peltonen; Raili Kauppinen
Acute intermittent porphyria: expression of mutant and wild-type porphobilinogen deaminase in COS-1 cells.
Molecular medicine (Cambridge, Mass.) 2000;6(8):670-9.
2000: B Stenius-Aarniala; Tuija Poussa; J Kvarnström; E L Grönlund; M Ylikahri; Pertti Mustajoki
Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study.
BMJ (Clinical research ed.) 2000;320(7238):827-32.
1999: Pertti Mustajoki; Tuula Pekkarinen
Maintenance programmes after weight reduction--how useful are they?
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(6):553-5.
1999: Miina Ohman; Laura J Oksanen; K Kainulainen; O A Jänne; Jaakko Kaprio; Markku Koskenvuo; Pertti Mustajoki; Kimmo Kontula; Leena Peltonen
Testing of human homologues of murine obesity genes as candidate regions in Finnish obese sib pairs.
European journal of human genetics : EJHG 1999;7(2):117-24.
1999: Sami Mustajoki; Heikki Ahola; Pertti Mustajoki; Raili Kauppinen
Insertion of Alu element responsible for acute intermittent porphyria.
Human mutation 1999;13(6):431-8.
1998: J Lojander; Pertti Mustajoki; S Rönkä; P Mecklin; Paula Maasilta
A nurse-managed weight reduction programme for obstructive sleep apnoea syndrome.
Journal of internal medicine 1998;244(3):251-5.
1998: Tuula Pekkarinen; I Takala; Pertti Mustajoki
Weight loss with very-low-calorie diet and cardiovascular risk factors in moderately obese women: one-year follow-up study including ambulatory blood pressure monitoring.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(7):661-6.
1998: Laura J Oksanen; Jaakko Kaprio; Pertti Mustajoki; Kimmo Kontula
A common pentanucleotide polymorphism of the 3'-untranslated part of the leptin receptor gene generates a putative stem-loop motif in the mRNA and is associated with serum insulin levels in obese individuals.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(7):634-40.
1998: Sami Mustajoki; H Pihlaja; Heikki Ahola; Niels Erik Petersen; Pertti Mustajoki; Raili Kauppinen
Three splicing defects, an insertion, and two missense mutations responsible for acute intermittent porphyria.
Human genetics 1998;102(5):541-8.
1998: R Tenhunen; Pertti Mustajoki
Acute porphyria: treatment with heme.
Seminars in liver disease 1998;18(1):53-5.
1997: Tuula Pekkarinen; Pertti Mustajoki
Use of very low-calorie diet in preoperative weight loss: efficacy and safety.
Obesity research 1997;5(6):595-602.
1997: Sami Mustajoki; Raili Kauppinen; Pertti Mustajoki; Anu Suomalainen; Leena Peltonen
Steady-state transcript levels of the porphobilinogen deaminase gene in patients with acute intermittent porphyria.
Genome research 1997;7(11):1054-60.
1997: Tuula Pekkarinen; Pertti Mustajoki
Comparison of behavior therapy with and without very-low-energy diet in the treatment of morbid obesity. A 5-year outcome.
Archives of internal medicine 1997;157(14):1581-5.
1997: Laura J Oksanen; K Kainulainen; M Heiman; Pertti Mustajoki; R Kauppinen-Mäkelin; Kimmo Kontula
Novel polymorphism of the human ob gene promoter in lean and morbidly obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(6):489-94.
1997: Laura J Oksanen; Miina Ohman; M Heiman; K Kainulainen; Jaakko Kaprio; Pertti Mustajoki; Veikko Koivisto; Markku Koskenvuo; O A Jänne; Leena Peltonen; Kimmo Kontula
Markers for the gene ob and serum leptin levels in human morbid obesity.
Human genetics 1997;99(5):559-64.
1997: Raili Kauppinen; Kaisa Timonen; Pertti Mustajoki
[Gene diagnostics and treatment of porphyrias].
Duodecim; lääketieteellinen aikakauskirja 1997;113(15):1487-92.
1997: HM Nissen; Niels Erik Petersen; Sami Mustajoki; Thomas S Hansen; Pertti Mustajoki; Raili Kauppinen; Mogens Hørder
Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis.
Human mutation 1997;9(2):122-30.
1996: Laura J Oksanen; Pertti Mustajoki; Jaakko Kaprio; K Kainulainen; O Jänne; Leena Peltonen; Kimmo Kontula
Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(12):1055-61.
1996: Katri Hakala; Pertti Mustajoki; J Aittomäki; Anssi Sovijärvi
Improved gas exchange during exercise after weight loss in morbid obesity.
Clinical physiology (Oxford, England) 1996;16(3):229-38.
1996: Tuula Pekkarinen; I Takala; Pertti Mustajoki
Two year maintenance of weight loss after a VLCD and behavioural therapy for obesity: correlation to the scores of questionnaires measuring eating behaviour.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(4):332-7.
1996: M Henriksson; K Timonen; Pertti Mustajoki; H Pihlaja; R Tenhunen; Leena Peltonen; Raili Kauppinen
Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients.
The Journal of investigative dermatology 1996;106(2):346-50.
1995: Katri Hakala; Pertti Mustajoki; J Aittomäki; Anssi Sovijärvi
Effect of weight loss and body position on pulmonary function and gas exchange abnormalities in morbid obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19(5):343-6.
1995: Raili Kauppinen; Sami Mustajoki; H Pihlaja; Leena Peltonen; Pertti Mustajoki
Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene.
Human molecular genetics 1995;4(2):215-22.
1994: Pertti Mustajoki; Sami Mustajoki; Arja Rautio; P Arvela; Olavi Pelkonen
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men.
Clinical pharmacology and therapeutics 1994;56(1):9-13.
1994: Raili Kauppinen; K Timonen; Pertti Mustajoki
Treatment of the porphyrias.
Annals of medicine 1994;26(1):31-8.
1993: Pertti Mustajoki; Y Nordmann
Early administration of heme arginate for acute porphyric attacks.
Archives of internal medicine 1993;153(17):2004-8.
1992: Pertti Mustajoki; K Timonen; A Gorchein; A M Seppäläinen; E Matikainen; R Tenhunen
Sustained high plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms.
European journal of clinical investigation 1992;22(6):407-11.
1992: Pertti Mustajoki; Raili Kauppinen; Lars Lannfelt; L Lilius; J Koistinen
Frequency of low erythrocyte porphobilinogen deaminase activity in Finland.
Journal of internal medicine 1992;231(4):389-95.
1992: Pertti Mustajoki; Jaakko-Juhani Himberg; O Tokola; R Tenhunen
Rapid normalization of antipyrine oxidation by heme in variegate porphyria.
Clinical pharmacology and therapeutics 1992;51(3):320-4.
1992: Raili Kauppinen; Pertti Mustajoki
Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases.
Medicine 1992;71(1):1-13.
1992: Raili Kauppinen; Leena Peltonen; H Pihlaja; Pertti Mustajoki
CRIM-positive mutations of acute intermittent porphyria in Finland.
Human mutation 1992;1(5):392-6.
1991: K Timonen; Katri Niemi; Pertti Mustajoki
Skin morphology in porphyria cutanea tarda does not improve despite clinical remission.
Clinical and experimental dermatology 1991;16(5):355-8.
1991: T Sane; Pertti Mustajoki; M Välimäki
Insulin therapy in maturity-onset diabetes.
Annals of medicine 1991;23(1):13-9.
1990: K Timonen; Pertti Mustajoki; R Tenhunen; J Lauharanta
Effects of haem arginate on variegate porphyria.
The British journal of dermatology 1990;123(3):381-7.
1990: Raili Kauppinen; Leena Peltonen; A Palotie; Pertti Mustajoki
RFLP analysis of three different types of acute intermittent porphyria.
Human genetics 1990;85(2):160-4.
1990: K Timonen; Katri Niemi; Pertti Mustajoki; R Tenhunen
Skin changes in variegate porphyria. Clinical, histopathological, and ultrastructural study.
Archives of dermatological research 1990;282(2):108-14.
1990: Pertti Mustajoki
Role of intracellular heme.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1990;202():63-4.
1990: K Timonen; Pertti Mustajoki; H Halme
[Porphyrias with cutaneous changes in Finland].
Duodecim; lääketieteellinen aikakauskirja 1990;106(21):1422-9.
1989: Pertti Mustajoki; R Tenhunen; C Pierach; Liisa Volin
Heme in the treatment of porphyrias and hematological disorders.
Seminars in hematology 1989;26(1):1-9.
1988: O Tokola; Pertti Mustajoki; Jaakko-Juhani Himberg
Haem arginate improves hepatic oxidative metabolism in variegate porphyria.
British journal of clinical pharmacology 1988;26(6):753-7.
1988: Raili Kauppinen; Pertti Mustajoki
Acute hepatic porphyria and hepatocellular carcinoma.
British journal of cancer 1988;57(1):117-20.
1987: Pertti Mustajoki; R Tenhunen; Katri Niemi; Y Nordmann; Helena Kääriäinen; Reijo Norio
Homozygous variegate porphyria. A severe skin disease of infancy.
Clinical genetics 1987;32(5):300-5.
1986: O Tokola; R Tenhunen; Liisa Volin; Pertti Mustajoki
Pharmacokinetics of intravenously administered haem arginate.
British journal of clinical pharmacology 1986;22(3):331-5.
1986: Pertti Mustajoki; R Tenhunen; O Tokola; G Gothoni
Haem arginate in the treatment of acute hepatic porphyrias.
British medical journal (Clinical research ed.) 1986;293(6546):538-9.